AI-generated summary
The authors treated seven adolescents or young adults with bipolar disorder and persistent depressive symptoms using bright light therapy added to their existing medication. Three patients showed a marked response, two a moderate response, and two little or none, with no reported side effects. The authors describe these as preliminary results, noting that some patients could potentially benefit.
- Participants
- 7
- Who or what was studied
- Adolescents or young adults aged 16 to 22 years with DSM-III-R bipolar disorder and persistent depressive symptoms
- Limits stated in the abstract
- The study was small and preliminary, with no control group, and the authors describe the results as preliminary.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Depression, Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.